Synthesis of phenstatin/isocombretastatin-chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers.

@article{Kamal2015SynthesisOP,
  title={Synthesis of phenstatin/isocombretastatin-chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers.},
  author={Ahmed Kamal and Gajjela Bharath Kumar and M. Vishnuvardhan and Anver Basha Shaik and Vangala Santhosh Reddy and Rasala Mahesh and Ibrahim Bin Sayeeda and Jeevak Sopanrao Kapure},
  journal={Organic \& biomolecular chemistry},
  year={2015},
  volume={13 13},
  pages={
          3963-81
        }
}
A series of phenstatin/isocombretastatin–chalcones were synthesized and screened for their cytotoxic activity against various human cancer cell lines. Some representative compounds exhibited significant antiproliferative activity against a panel of sixty human cancer cell lines of the NCI, with GI50 values in the range of 0.11 to 19.0 μM. Three compounds (3b, 3c and 3e) showed a broad spectrum of antiproliferative efficacy on most of the cell lines in the sub-micromolar range. In addition, all… 
Combretastatin-Inspired Heterocycles as Antitubulin Anticancer Agents
TLDR
The results revealed the importance of the 2-aminoimidazole-carbonyl motif as a double bond replacement in combretastatin and indicated a pharmacodynamically interesting pattern of H-bond acceptors/donors and requisite syn-templated aryls.
An orally antitumor chalcone hybrid inhibited HepG2 cells growth and migration as the tubulin binding agent
TLDR
Compound 9 displayed the antitumor activity against liver cancer HepG2 cells in vivo with the low toxicity toward mice and deserves further investigation to treat liver cancer.
A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells
TLDR
The data suggest that 3MCIC is a promising anticancer lead compound with novel targeting mechanisms, and also demonstrate the efficiency of LAC-MS based target identification in anticancer drug development.
Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
TLDR
A series of hybrid of triazoloquinoxaline-chalcone derivatives 7a–k were designed, synthesized, fully characterized, and evaluated for their cytotoxic activity against three target cell lines, showing significant antiproliferative effects against most of the cell lines.
Synthesis and Biological Evaluation of 1,2,3‐triazole tethered Pyrazoline and Chalcone Derivatives
TLDR
A series of pyrazoline derivatives and corresponding chalcone intermediates with substituents same as combretastatin‐A4(CA‐4) conjugated with triazole nucleus has been synthesized and evaluated for their anticancer potential, indicating their ability to trigger apoptosis.
...
1
2
3
4
...

References

SHOWING 1-10 OF 65 REFERENCES
Design and Synthesis of Aminostilbene–Arylpropenones as Tubulin Polymerization Inhibitors
TLDR
A series of aminostilbene—arylpropenones designed and synthesized by Michael addition were investigated for their cytotoxic activity against various human cancer cell lines and molecular docking studies indicated that these compounds occupy the colchicine binding site of tubulin.
Synthesis and Biological Evaluation of Imidazopyridine–Oxindole Conjugates as Microtubule‐Targeting Agents
TLDR
Flow cytometric analysis showed that MCF‐7 cells treated by these compounds arrested in the G2/M phase of the cell cycle in a concentration‐dependent manner, and docking of compound 10 f with tubulin protein suggested that the imidazo[1,2‐a]pyridine moiety occupies the colchicine binding site of tubulin.
Synthesis, Biological Evaluation of 1,1‐Diarylethylenes as a Novel Class of Antimitotic Agents
TLDR
The cytotoxic activities of 23 new isocombretastatin A derivatives with modifications on the B‐ring were investigated, and the disruptive effect of 2’e, 2 k and 2‬s on the vessel‐like structures formed by human umbilical vein endothelial cells (HUVEC) suggest that these compounds may act as vascular disrupting agents.
Synthesis and Antitumor Evaluation of Nitrovinyl Biphenyls: Anticancer Agents Based on Allocolchicines
A new class of nitrovinyl biphenyl compounds based on the structures of colchicines and allocolchicines were designed, synthesized, and shown to inhibit tubulin polymerization and cause mitotic
Design, synthesis and biological evaluation of imidazopyridine/imidazopyrimidine-benzimidazole conjugates as potential anticancer agents
TLDR
The present study demonstrates that the synthesis of imidazopyridine/imidZopyrimidine-benzimidazole conjugates as promising tubulin inhibitors with G2/M phasecell cycle arrest and apoptotic-inducing ability.
Synthesis of terphenyl benzimidazoles as tubulin polymerization inhibitors.
Design and synthesis of resveratrol-based nitrovinylstilbenes as antimitotic agents.
TLDR
Docking of compounds 7c and 7e with tubulin suggested that the A-ring of the compounds occupies the colchicine binding site of tubulin, and that the nitrovinyl side chain forms two hydrogen bonds with the main loop of the β-chain at Asn249 and Ala250.
Synthesis and antitumor activity of benzils related to combretastatin A-4.
Chalcones: an update on cytotoxic and chemoprotective properties.
TLDR
The thiol reactivity of chalcones is likely to contribute to both cytotoxic and chemoprotective properties of these compounds.
Antineoplastic agents. 379. Synthesis of phenstatin phosphate.
TLDR
Phenstatin (3b) inhibited growth of the pathogenic bacterium Neisseriagonorrhoeae and was a potent inhibitor of tubulin polymerization and the binding of colchicine to tubulin comparable to combretastatin A-4 (1b).
...
1
2
3
4
5
...